Your browser doesn't support javascript.
loading
Is there a ceiling lamotrigine serum level in epileptic children in remission?
Charfi, Rim; Gaies, Emna; Ben Sassi, Mouna; El Jebari, Hanene; Kammoun, Rania; Dahmene, Israa; Jebabli, Nadia; Salouage, Issam; Daghfous, Riadh; Trabelsi, Sameh.
Afiliação
  • Charfi R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia. Electronic address: charfirim@yahoo.fr.
  • Gaies E; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Ben Sassi M; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • El Jebari H; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Kammoun R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Dahmene I; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Jebabli N; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Salouage I; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Daghfous R; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
  • Trabelsi S; University of Tunis El Manar, Faculty of de Medicine of Tunis, National Centre Chalbi Belkahia of Pharmacovigilance, Department of clinical pharmacology, Research Laboratory of Clinical and Experimental Pharmacology (LR16SP02), 1006 Tunis, Tunisia.
Therapie ; 77(4): 461-466, 2022.
Article em En | MEDLINE | ID: mdl-34973822
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia Generalizada / Epilepsia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epilepsia Generalizada / Epilepsia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article